Clinical Trial Update: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating cisplatin, pemetrexed, and imatinib mesylate for malignant mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Imatinib mesylate (Imatinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Mesothelioma | Phase 1 | Status: COMPLETED